Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D

Jeah (Kyoungrae) Jung, Roger Feldman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: To examine variation in risk-adjusted reinsurance payments across Part D plans, analyze its implications for the program, and explore options to reduce reinsurance payments. Data/Study Design: 2007–2015 Part D Plan Payment and Premium data; 2010–2013 Part D Prescription Drug Event data; and 2013 Part D Plan Formulary Files. Principal Findings: Risk-adjusted reinsurance payments varied widely across plans at a given out-of-pocket (OOP) premium. The variance in risk-adjusted reinsurance in common OOP premium ranges increased between 2010 and 2015. High risk-adjusted reinsurance payments were negatively correlated with use of utilization management tools for high-cost drugs. Conclusions: Growing reinsurance payments shrink plans’ liability for managing drug spending for high-cost enrollees, creating plan moral hazard, and making OOP premiums a noisy signal of plans’ total costs.

Original languageEnglish (US)
Pages (from-to)4371-4380
Number of pages10
JournalHealth Services Research
Volume53
Issue number6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Competitive Bidding
Medicare Part D
Formularies
Costs and Cost Analysis
Drug Costs
Prescription Drugs
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

@article{d08afc211fc4487fb19d1e2d235c2960,
title = "Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D",
abstract = "Objectives: To examine variation in risk-adjusted reinsurance payments across Part D plans, analyze its implications for the program, and explore options to reduce reinsurance payments. Data/Study Design: 2007–2015 Part D Plan Payment and Premium data; 2010–2013 Part D Prescription Drug Event data; and 2013 Part D Plan Formulary Files. Principal Findings: Risk-adjusted reinsurance payments varied widely across plans at a given out-of-pocket (OOP) premium. The variance in risk-adjusted reinsurance in common OOP premium ranges increased between 2010 and 2015. High risk-adjusted reinsurance payments were negatively correlated with use of utilization management tools for high-cost drugs. Conclusions: Growing reinsurance payments shrink plans’ liability for managing drug spending for high-cost enrollees, creating plan moral hazard, and making OOP premiums a noisy signal of plans’ total costs.",
author = "Jung, {Jeah (Kyoungrae)} and Roger Feldman",
year = "2018",
month = "12",
day = "1",
doi = "10.1111/1475-6773.12866",
language = "English (US)",
volume = "53",
pages = "4371--4380",
journal = "Health Services Research",
issn = "0017-9124",
publisher = "Wiley-Blackwell",
number = "6",

}

Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D. / Jung, Jeah (Kyoungrae); Feldman, Roger.

In: Health Services Research, Vol. 53, No. 6, 01.12.2018, p. 4371-4380.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D

AU - Jung, Jeah (Kyoungrae)

AU - Feldman, Roger

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Objectives: To examine variation in risk-adjusted reinsurance payments across Part D plans, analyze its implications for the program, and explore options to reduce reinsurance payments. Data/Study Design: 2007–2015 Part D Plan Payment and Premium data; 2010–2013 Part D Prescription Drug Event data; and 2013 Part D Plan Formulary Files. Principal Findings: Risk-adjusted reinsurance payments varied widely across plans at a given out-of-pocket (OOP) premium. The variance in risk-adjusted reinsurance in common OOP premium ranges increased between 2010 and 2015. High risk-adjusted reinsurance payments were negatively correlated with use of utilization management tools for high-cost drugs. Conclusions: Growing reinsurance payments shrink plans’ liability for managing drug spending for high-cost enrollees, creating plan moral hazard, and making OOP premiums a noisy signal of plans’ total costs.

AB - Objectives: To examine variation in risk-adjusted reinsurance payments across Part D plans, analyze its implications for the program, and explore options to reduce reinsurance payments. Data/Study Design: 2007–2015 Part D Plan Payment and Premium data; 2010–2013 Part D Prescription Drug Event data; and 2013 Part D Plan Formulary Files. Principal Findings: Risk-adjusted reinsurance payments varied widely across plans at a given out-of-pocket (OOP) premium. The variance in risk-adjusted reinsurance in common OOP premium ranges increased between 2010 and 2015. High risk-adjusted reinsurance payments were negatively correlated with use of utilization management tools for high-cost drugs. Conclusions: Growing reinsurance payments shrink plans’ liability for managing drug spending for high-cost enrollees, creating plan moral hazard, and making OOP premiums a noisy signal of plans’ total costs.

UR - http://www.scopus.com/inward/record.url?scp=85046537756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046537756&partnerID=8YFLogxK

U2 - 10.1111/1475-6773.12866

DO - 10.1111/1475-6773.12866

M3 - Article

VL - 53

SP - 4371

EP - 4380

JO - Health Services Research

JF - Health Services Research

SN - 0017-9124

IS - 6

ER -